Plasma cells in systemic lupus erythematosus: The long and short of it all
Authors:
- 10 February 2011
- journal article
- editorial
- Published by Wiley in European Journal of Immunology
- Vol. 41 (3) , 588-591
Abstract
Plasma cells can be classified as long‐ or short‐lived. The lifespan of a plasma cell largely depends on whether it arises from a germinal center or an extrafollicular locus and most importantly whether it can find a survival niche in the spleen or BM. In systemic lupus erythematosus (SLE) patients, long‐lived plasma cells are believed to be responsible for the production of anti‐RNA and anti‐cardiolipin antibodies, whereas short‐lived plasma cells, which are more susceptible to anti‐proliferation therapies, are the main producers of anti‐DNA antibodies. A previous study showed that transient overexpression of interferon‐α (IFN‐α), a cytokine that plays a pathogenic role in SLE, accelerates disease onset in lupus‐prone NZB/W mice. In this issue of the European Journal of Immunology, the same group report that IFN‐α induces large numbers of short‐lived plasma cells, accompanied by high titers of anti‐dsDNA antibodies in NZB/W, but not BALB/c, mice. Our commentary discusses this interesting observation in the context of the previous data regarding plasma cell differentiation and conveys our view about the clinical implications with respect to therapies that target plasma cells in SLE patients.Keywords
This publication has 28 references indexed in Scilit:
- Interferon‐α induces unabated production of short‐lived plasma cells in pre‐autoimmune lupus‐prone (NZB×NZW)F1 mice but not in BALB/c miceEuropean Journal of Immunology, 2011
- Interferon‐α accelerates murine systemic lupus erythematosus in a T cell–dependent mannerArthritis & Rheumatism, 2010
- Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trialArthritis & Rheumatism, 2009
- Guidance of B Cells by the Orphan G Protein-Coupled Receptor EBI2 Shapes Humoral Immune ResponsesImmunity, 2009
- Interferon‐α treatment of female (NZW × BXSB)F1 mice mimics some but not all features associated with the Yaa mutationArthritis & Rheumatism, 2009
- Increased IL-12 inhibits B cells' differentiation to germinal center cells and promotes differentiation to short-lived plasmablastsJournal of Experimental Medicine, 2008
- Systemic IFN‐α drives kidney nephritis in B6.Sle123 miceEuropean Journal of Immunology, 2008
- Anti‐chromatin antibodies drive in vivo antigen‐specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sitesEuropean Journal of Immunology, 2007
- High affinity germinal center B cells are actively selected into the plasma cell compartmentJournal of Experimental Medicine, 2006
- Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiationJournal of Experimental Medicine, 2006